All Stories

  1. Impact of Discontinuing Both Hypertonic Saline and Dornase Alfa after Elexacaftor-Tezacaftor-Ivacaftor in Cystic Fibrosis

    Article • Annals of the American Thoracic Society, November 2024, American Thoracic Society

    Theodore Liou

  2. Predicting weight gain in patients with cystic fibrosis on triple combination modulator

    Article • Pediatric Pulmonology, April 2024, Wiley

    Theodore Liou

  3. A comparison of aminoglycoside antibiotic serum concentrations collected by peripheral veins and peripherally inserted central catheters in adults with cystic fibrosis

    Article • Pediatric Pulmonology, March 2024, Wiley

    Theodore Liou

  4. Airway inflammation accelerates pulmonary exacerbations in cystic fibrosis

    Article • iScience, March 2024, Elsevier

    Theodore Liou

  5. Mutations in the C-terminal region of the bacteriophage exclusion protein PglX can selectively inactivate restriction in Salmonella

    Article • Journal of Bacteriology, October 2023, ASM Journals

    Theodore Liou

  6. Inhaled mRNA therapy for treatment of cystic fibrosis: Interim results of a randomized, double‐blind, placebo‐controlled phase 1/2 clinical study

    Article • Journal of Cystic Fibrosis, July 2023, Elsevier

    Theodore Liou

  7. Lung Function Decline in Cystic Fibrosis: Impact of Data Availability and Modeling Strategies on Clinical Interpretations

    Article • Annals of the American Thoracic Society, July 2023, American Thoracic Society

    Theodore Liou

  8. Safety and efficacy of vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials

    Article • The Lancet Respiratory Medicine, June 2023, Elsevier

    Theodore Liou

  9. Calibration and validation of modeled 5-year survival predictions among people with cystic fibrosis treated with the cystic fibrosis transmembrane conductance regulator modulator ivacaftor using United States registry data

    Article • PLOS One, April 2023, PLOS

    Theodore Liou

  10. Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials

    Article • The Lancet Respiratory Medicine, April 2023, Elsevier

    Theodore Liou

  11. Associations of Sputum Biomarkers with Clinical Outcomes in People with Cystic Fibrosis

    Article • May 2022, Cold Spring Harbor Laboratory Press

    Theodore Liou

  12. Spotlighting “Neutrophil Elastase Triggers the Release of Macrophage Extracellular Traps”: A New Catch in Cystic Fibrosis?

    Article • American Journal of Respiratory Cell and Molecular Biology, January 2022, American Thoracic Society

    Theodore Liou

  13. Forced Expiratory Flow at 25%-75% Links COPD Physiology to Emphysema and Disease Severity in the SPIROMICS Cohort

    Article • Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation, January 2022, COPD Foundation

    Theodore Liou, Mehrdad Arjomandi

  14. Enhanced epithelial sodium channel activity in neonatal Scnn1b mouse lung attenuates high oxygen-induced lung injury

    Article • AJP Lung Cellular and Molecular Physiology, July 2021, American Physiological Society

    Theodore Liou

  15. Long-term safety and efficacy of tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study

    Article • The Lancet Respiratory Medicine, July 2021, Elsevier

    Theodore Liou

  16. Hypoxia induces expression of angiotensin‐converting enzyme II in alveolar epithelial cells: Implications for the pathogenesis of acute lung injury in COVID‐19

    Article • Physiological Reports, May 2021, Wiley

    Theodore Liou

  17. SARS‐CoV‐2 innate effector associations and viral load in early nasopharyngeal infection

    Article • Physiological Reports, February 2021, Wiley

    Theodore Liou

  18. The Uncertain Role of Corticosteroids in the Treatment of COVID-19

    Article • JAMA Internal Medicine, January 2021, American Medical Association (AMA)

    Theodore Liou

  19. SARS-CoV-2 Innate Effector Associations and Viral Load in Early Nasopharyngeal Infection

    Article • November 2020, Cold Spring Harbor Laboratory Press

    Theodore Liou

  20. Impact of low-level fine particulate matter and ozone exposure on absences in K-12 students and economic consequences

    Article • Environmental Research Letters, November 2020, Institute of Physics Publishing

    Theodore Liou

  21. Evaluation of a five-year predicted survival model for cystic fibrosis in later time periods

    Article • Scientific Reports, April 2020, Springer Science + Business Media

    Theodore Liou

  22. High-mobility group box-1 increases epithelial sodium channel activity and inflammation via the receptor for advanced glycation end products

    Article • AJP Cell Physiology, March 2020, American Physiological Society

    Theodore Liou

  23. Refinement of metabolite detection in cystic fibrosis sputum reveals heme correlates with lung function decline

    Article • PLOS One, December 2019, PLOS

    Theodore Liou

  24. A multi-scale approach to study biochemical and biophysical aspects of resveratrol on diesel exhaust particle-human primary lung cell interaction

    Article • Scientific Reports, December 2019, Springer Science + Business Media

    Theodore Liou

  25. Longer Life or More Life: Choose One Please

    Article • Journal of Surgical Research, May 2019, Elsevier

    Theodore Liou

  26. Prospective multicenter randomized patient recruitment and sample collection to enable future measurements of sputum biomarkers of inflammation in an observational study of cystic fibrosis

    Article • BMC Medical Research Methodology, April 2019, Springer Science + Business Media

    Theodore Liou

  27. RV/LV ratio in severe sepsis and septic shock: Response to Letter to the Editor

    Article • Journal of Critical Care, April 2019, Elsevier

    Theodore Liou

  28. The Clinical Biology of Cystic Fibrosis Transmembrane Regulator Protein

    Article • CHEST Journal, March 2019, Elsevier

    Theodore Liou

  29. Modeling long-term health outcomes of patients with cystic fibrosis homozygous for F508del-CFTR treated with lumacaftor/ivacaftor

    Article • Therapeutic Advances in Respiratory Disease, January 2019, SAGE Publications

    Theodore Liou

  30. Right-to-left ventricular end diastolic diameter ratio in severe sepsis and septic shock

    Article • Journal of Critical Care, December 2018, Elsevier

    Theodore Liou

  31. Refinement of metabolite detection in cystic fibrosis sputum reveals heme negatively correlates with lung function

    Article • November 2018, Cold Spring Harbor Laboratory Press

    Theodore Liou

  32. Pharmacokinetics of Continuous Infusion Beta-lactams in the Treatment of Acute Pulmonary Exacerbations in Adult Patients With Cystic Fibrosis

    Article • CHEST Journal, November 2018, Elsevier

    Theodore Liou

  33. Population Pharmacokinetics of Amikacin in Adult Patients with Cystic Fibrosis

    Article • Antimicrobial Agents and Chemotherapy, July 2018, ASM Journals

    Theodore Liou, Dr Catherine Sherwin

  34. Thailandamide, a Fatty Acid Synthesis Antibiotic That Is Coexpressed with a Resistant Target Gene

    Article • Antimicrobial Agents and Chemotherapy, June 2018, ASM Journals

    Theodore Liou

  35. Micro-organisms that live in the airway of CF patients interact with each other

    Article • Journal of Clinical Microbiology, May 2018, ASM Journals

    Theodore Liou

  36. Cystic Fibrosis Colorectal Cancer Screening Consensus Recommendations

    Article • Gastroenterology, February 2018, Elsevier

    Theodore Liou

  37. Sleep Phase Delay in Cystic Fibrosis

    Article • CHEST Journal, August 2017, Elsevier

    Theodore Liou

  38. The Dynamics of Disease Progression in Cystic Fibrosis

    Article • PLOS One, June 2016, PLOS

    Theodore Liou

  39. Improving performance in the detection and management of cystic fibrosis-related diabetes in the Mountain West Cystic Fibrosis Consortium

    Article • BMJ Open Diabetes Research & Care, April 2016, BMJ

    Theodore Liou

  40. Forced Expiratory Volume in 1 Second Variability Helps Identify Patients with Cystic Fibrosis at Risk of Greater Loss of Lung Function

    Article • The Journal of Pediatrics, February 2016, Elsevier

    Theodore Liou

  41. Adolescents with cystic fibrosis: Take the door, not the window

    Article • Pediatric Transplantation, January 2015, Wiley

    Theodore Liou

  42. Rib plating of acute and sub-acute non-union rib fractures in an adult with cystic fibrosis: a case report

    Article • BMC Research Notes, October 2014, Springer Science + Business Media

    Theodore Liou

  43. Genetic Discovery, Rigorous Statistics, and Pandemic Influenza

    Article • CHEST Journal, June 2014, Elsevier

    Theodore Liou

  44. Use of older donors for lung transplantation—you can’t get there from here

    Article • The Journal of Heart and Lung Transplantation, August 2013, Elsevier

    Theodore Liou

  45. Lung transplantation for chronic obstructive pulmonary disease

    Article • Transplant Research and Risk Management, July 2013, Taylor & Francis

    Theodore Liou

  46. Toxicity effects of short term diesel exhaust particles exposure to human small airway epithelial cells (SAECs) and human lung carcinoma epithelial cells (A549)

    Article • Toxicology Letters, December 2012, Elsevier

    Theodore Liou

  47. Ivacaftor in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del-CFTR Mutation

    Article • CHEST Journal, September 2012, Elsevier

    Theodore Liou

  48. Sputum Biomarkers and the Prediction of Clinical Outcomes in Patients with Cystic Fibrosis

    Article • PLOS One, August 2012, PLOS

    Theodore Liou

  49. Delay in Recognition of Pulmonary Arterial Hypertension

    Article • CHEST Journal, July 2011, Elsevier

    Theodore Liou

  50. Denufosol Tetrasodium in Patients with Cystic Fibrosis and Normal to Mildly Impaired Lung Function

    Article • American Review of Respiratory Disease, March 2011, American Thoracic Society

    Theodore Liou, Professor Richard B Moss

  51. The Changing Picture of Patients With Pulmonary Arterial Hypertension in the United States

    Article • CHEST Journal, January 2011, Elsevier

    Theodore Liou

  52. Predicting Survival in Pulmonary Arterial Hypertension

    Article • Circulation, July 2010, Wolters Kluwer Health

    Theodore Liou

  53. Year-to-year changes in lung function in individuals with cystic fibrosis

    Article • Journal of Cystic Fibrosis, July 2010, Elsevier

    Theodore Liou

  54. Pulmonary Arterial Hypertension

    Article • CHEST Journal, February 2010, Elsevier

    Theodore Liou

  55. Efficacy and Safety of a New Formulation of Pancrelipase (Ultrase MT20) in the Treatment of Malabsorption in Exocrine Pancreatic Insufficiency in Cystic Fibrosis

    Article • Gastroenterology Research and Practice, January 2010, Hindawi Publishing Corporation

    Theodore Liou

  56. Carrier Screening, Incidence of Cystic Fibrosis, and Difficult Decisions

    Article • JAMA, December 2009, American Medical Association (AMA)

    Theodore Liou

  57. Lung Transplantation for Cystic Fibrosis

    Article • Proceedings of the American Thoracic Society, December 2009, American Thoracic Society

    Theodore Liou

  58. Insulin Therapy to Improve BMI in Cystic Fibrosis-Related Diabetes Without Fasting Hyperglycemia: Results of the Cystic Fibrosis Related Diabetes Therapy Trial

    Article • Diabetes Care, July 2009, American Diabetes Association

    Theodore Liou

  59. Spirometry

    Article • Clinical Reviews in Allergy & Immunology, April 2009, Springer Science + Business Media

    Theodore Liou

  60. Measurement of Lung Volumes

    Article • Clinical Reviews in Allergy & Immunology, April 2009, Springer Science + Business Media

    Theodore Liou

  61. Pediatric Lung Transplantation for Cystic Fibrosis

    Article • Transplantation, September 2008, Wolters Kluwer Health

    Theodore Liou

  62. Design of the REVEAL Registry for US Patients With Pulmonary Arterial Hypertension

    Article • Mayo Clinic Proceedings, August 2008, Elsevier

    Theodore Liou

  63. Outcomes of Care by Hospitalists

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, April 2008, New England Journal of Medicine (NEJM/MMS)

    Theodore Liou

  64. Lung Transplantation and Survival in Children with Cystic Fibrosis

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, November 2007, New England Journal of Medicine (NEJM/MMS)

    Theodore Liou

  65. A phase 2 study of aztreonam lysine for inhalation to treat patients with cystic fibrosis andPseudomonas aeruginosa infection

    Article • Pediatric Pulmonology, January 2007, Wiley

    Theodore Liou

  66. Lung transplantation for cystic fibrosis

    Article • Current Opinion in Pulmonary Medicine, November 2006, Wolters Kluwer Health

    Theodore Liou

  67. BIVENTRICULAR FAILURE POST TAMPONADE DRAINAGE IN A PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND PULMONARY HYPERTENSION

    Article • CHEST Journal, October 2005, Elsevier

    Theodore Liou

  68. Epidemiology of cystic fibrosis-related diabetes

    Article • The Journal of Pediatrics, May 2005, Elsevier

    Theodore Liou

  69. Use of Lung Transplantation Survival Models to Refine Patient Selection in Cystic Fibrosis

    Article • American Review of Respiratory Disease, May 2005, American Thoracic Society

    Theodore Liou

  70. Selection of patients with cystic fibrosis for lung transplantation

    Article • Current Opinion in Pulmonary Medicine, November 2002, Wolters Kluwer Health

    Theodore Liou

  71. Predictive 5-Year Survivorship Model of Cystic Fibrosis

    Article • American Journal of Epidemiology, February 2001, Oxford University Press (OUP)

    Theodore Liou

  72. Nonisotropic Enzyme-Inhibitor Interactions: A Novel Nonoxidative Mechanism for Quantum Proteolysis by Human Neutrophils

    Article • Biochemistry, December 1995, American Chemical Society (ACS)

    Theodore Liou